Download Our Phosphate Binding Study
This study critically examined the efficacy of phosphate binding by a new phosphate binder, calcium succinate monohydrate (CS), under three in vitro conditions designed to mimic phosphate binding in vivo. Experimental results were compared with phosphate binding by calcium acetate (PhosLo® gelcaps), under the same conditions.
Download Our Literature Review: Magnesium Inclusion in Phosphate Binders
GI absorption of diet-derived phosphate may be lowered and controlled by cations such as calcium and magnesium. Since both physiological metals bind phosphate, what may be observed if they are used in combination?
US8759398B2: Phosphorus Binder Composition For Treatment of Hyperphosphatemia
This BioLink patent illustrates our unique approach to addressing unmet needs and enhancing patient care. By selecting calcium succinate we identified a phosphate binder that exhibited equivalent phosphate-binding properties to calcium acetate in vitro but could not generate a volatile, irritating acid. Moreover, succinate is an integral part of human metabolism and the tricarboxylic acid cycle.
Download AHA Graphical Abstract
AHA Graphical Abstract - Magnesium Counteracts Vascular Calcification.
BioLink is a specialty pharmaceutical company focused on the development and commercialization of patented treatments... Learn more here...
Learn more about Phosveda:
How Phosveda Works
Reducing serum phosphorus levels by binding dietary phosphates in the gastrointestinal tract continues to be a focus of treatment of CKD.
Partner With Us
We believe in creating treatments that meet the needs of underserved patient populations and we are looking for companies and individuals to partner with us on our mission.
Learn more here...
On Target For Phosphate Binding
Calcium salts are effective, inexpensive, and widely used phosphate binders.
Learn more about Phosveda by downloading the following resources.
Download BioLink ASN Conference Presentation Material
Information presented that the 2019 ASN Conference.
Partner With Us
At BioLink, we are always looking for terrific partners for our suite of products and patented molecules who can help us effectively reach appropriate patients and the clinicians who treat them. If you have an interest in Phosveda or any other BioLink assets, please reach out to us at email@example.com or 919-678-9478.